Mark Pool, MD's Posts

Pulmonary Arterial Enlargement and Acute Exacerbations of COPD — NEJM by Mark Pool, MD Posted in: Blog Posts in Cancer Interesting article more from the radiology perspective but it would be interesting to know if there is an autopsy study of pathological findings that would corroborate the ... Read on »

Hypermethylation in non-small cell lung carcinoma by Mark Pool, MD Posted in: Blog Posts in Cancer After an uncomfortably long hiatus from The Daily Sign-Out, I'm back. Nothing serious, just summertime distractions (fun!) and intense preparation for our lab's upcoming CAP ... Read on »

"Transfusion News" a new site launched by AABB and Ortho Clinical Diagnostics by Mark Pool, MD Posted in: Blog Posts in Cancer Check out this new web site for transfusion-related news. Excellent site design and content. AABB has partnered with Ortho Clinical Diagnostics to launch Transfusion News, a ... Read on »

Recommended Article: Health Care Reform and the Laws of Unintended Consequences by Mark Pool, MD Posted in: Blog Posts in Cancer Excellent and thoughtful post not only for those interested in healthcare policy but for anyone interested in 20th century American history. I'd be interested in checking ou ... Read on »

Evidence for lung regeneration in an adult: case report by Mark Pool, MD Posted in: Blog Posts in Cancer The conventional view is that lung growth and development ends around age 7 but a fascinating article in last week's NEJM (N Engl J Med 2012; 367:244-247July 19, 2012) sugge ... Read on »

Pathology Visions 2012: Discounted registration opportunites by Mark Pool, MD Posted in: Blog Posts in Cancer If you're thinking of attending the 2012 Pathology Visions Conference, please note the following opportunities for discounted registration fees. Here's the info provided to ... Read on »

Genetically Distinct Subsets within ANCA-Associated Vasculitis — NEJM by Mark Pool, MD Posted in: Blog Posts in Cancer Genetically Distinct Subsets within ANCA-Associated Vasculitis — NEJM. Very interesting article on overlapping, uncommon, and enigmatic clinical syndromes that have an assoc ... Read on »

Field cancerization though precancerous stromal changes by Mark Pool, MD Posted in: Blog Posts in Cancer An important question in cancer research is the causes and mechanisms for the development of multifocal carcinomas, especially for non-small cell lung carcinomas (as I recen ... Read on »

The New IASLC/ATS/ERS Lung Adenocarcinoma Classification by Mark Pool, MD Posted in: Blog Posts in Cancer FYI-Excellent content for CME In 2011, the Journal for Thoracic Oncology published the "International Association for the Study of Lung Cancer/American Thoracic Society/Euro ... Read on »

Emergent respiratory viral pathogens by Mark Pool, MD Posted in: Blog Posts in Cancer Jartii et al provide an excellent review new viral respiratory infections in the May 2012 Current Opinion in Pulmonary Medicine in you are looking for a concise update on th ... Read on »

Techniques to increase lymph node harvest from gastrointestinal cancer specimens: a systematic... by Mark Pool, MD Posted in: Blog Posts in Cancer Good news/bad news. Another article supporting the use of fat clearing and methylene blue staining to increase lymph node yields in GI dissection BUT these techniques do not ... Read on »

Proadrenomedullin in prognosis of community-acquired pneumonia by Mark Pool, MD Posted in: Blog Posts in Cancer Community-acquired pneumonia is still a major healthcare problem and is under intense scrutiny as an "opportunity" to measure hospital performance (and thus determine reimbu ... Read on »

Implications of clonality in multifocal non small cell lung cancer by Mark Pool, MD Posted in: Blog Posts in Cancer About 5% to 8% of NSCLC patients present with 2 or more anatomically separate lung tumors at diagnosis. The distinction between synchronous primary tumors and intrapulmonary ... Read on »

New directions for lung squamous cell carcinoma by Mark Pool, MD Posted in: Blog Posts in Cancer For non-small cell lung cancer patients with localized or regional disease, treatment options vary little according to histology. For metastatic NSCLC "targeted" therapies f ... Read on »

Getting Ready for the ObamaCare Decision | e21 - Economic Policies for the 21st Century by Mark Pool, MD Posted in: Blog Posts in Cancer Supreme Suspense: Getting Ready for the Big ObamaCare Decision | e21 - Economic Policies for the 21st Century. This is a nicely written piece by James Capretta of the Americ ... Read on »

Establishing clonality in multifocal nonsmall cell lung cancer by Mark Pool, MD Posted in: Blog Posts in Cancer Up to 8% of nonsmall cell lung cancer (NSCLC) patients present with 2 or more anatomically separate lung tumors. Distinguishing between synchronous primary tumors and intrap ... Read on »

Flagship Biosciences Acquires IHCtech by Mark Pool, MD Posted in: Blog Posts in Cancer Flagship Biosciences released news today of their acquisition of IHCtech, a company founded by Patsy Ruegg in 2002 at the University of Colorado Health Sciences Center Patho ... Read on »

Call It Cancer by Mark Pool, MD Posted in: Blog Posts in Cancer A couple of recent editorials in The Oncologist have reacted to the recent NIH consensus panel on prostate cancer and this panel's statement that it may be "a mistake" to ca ... Read on »

Abstracts and Posters Accepted Now for Pathology Visions 2012 by Mark Pool, MD Posted in: Blog Posts in Cancer As a courtesy to the Digital Pathology Association, I am passing along this information regarding the 2012 Pathology Visions conference in Baltimore, Maryland from October 2 ... Read on »

New biomarkers for mesothelioma by Mark Pool, MD Posted in: Blog Posts in Cancer Today is a first for this blog--a guest post! I recently was contacted by Danielle DiPietro, National Awareness Director for the Mesothelioma Center at Asbestos.com to see i ... Read on »

Mark Pool, MD

Posts

Related Articles